4 min read
Great Place to Work® Designates Selexis as a Best Workplace in Switzerland for Fifth Straight Year
Geneva, Switzerland, May 11, 2022 – Selexis SA, a JSR Life Sciences Company, announced today that Great Place to Work®...
Geneva, Switzerland, May 11, 2022 – Selexis SA, a JSR Life Sciences Company, announced today that Great Place to Work®...
SUNNYVALE, California, May 2, 2022 – JSR Life Sciences, LLC (JSR) today announced that Mark W. Womack will serve as...
Geneva, Switzerland, March 11, 2022 – Selexis SA, a JSR Life Sciences company, today announced that its business and...
Selexis SA, a JSR Life Sciences company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines. Our global partners are utilizing Selexis technologies to advance more than 158 drug products in clinical development and the manufacture of 10 commercial products. As part of a comprehensive drug development process, the Company’s technologies shorten development timelines and reduce manufacturing risks. More information is available at www.selexis.com.
Copyright© 2022 Selexis SA. All Rights Reserved.